Articles for International Society for the Study of Drug Policy ISSDP

In an era where drug markets are shifting toward synthetic substances and global legal frameworks are being redefined, the need for rigorous, evidence-based analysis has never been more critical. The International Society for the Study of Drug Policy (ISSDP) stands at the forefront of this movement. Headquartered in the heart of Manchester, UK, this premier global society is dedicated to advancing the scientific base for drug policy decisions worldwide. The Genesis of ISSDP: From Vision to Global Authority The ISSDP was born out of a necessity for a vendor-neutral, scholarly space where the world’s leading analysts could debate the complex social, legal, and health impacts of drug use and regulation. Founded by Prof. Peter Reuter—a legendary figure in drug policy and criminology—the society held its inaugural conference in 2007. By 2009, it achieved formal status as a registered UK charity, cementing its role as a stable pillar for the international research community. Today, based at Manchester Metropolitan University (MMU), the ISSDP operates as a non-partisan bridge between high-level academic inquiry and the practical needs of policymakers. Core Mission: Bridging the Gap Between Science and Policy The ISSDP mission is built on four fundamental objectives: Providing a Leading Forum: Facilitating high-quality drug policy analysis that challenges existing paradigms. Developing Scientific Foundations: Strengthening the empirical evidence required for critical legislative and health decisions. Enhancing Researcher-Policymaker Interfaces: Ensuring that technical findings are translated into actionable policy. Fostering Global Cooperation: Encouraging comparative projects that transcend borders. Annual Scholarly International Conferences: The ISSDP Pulse The hallmark of the society is the ISSDP Annual Scientific Conference. These events rotate globally—from Mexico and Colombia to Australia and the UK—ensuring a truly international perspective. Multidisciplinary Reach: The conferences attract experts in criminology, public health economics, sociology, and international law. Emerging Scholars: Through Research Scholarships, the ISSDP actively mentors doctoral students and researchers from the Global South, ensuring that the future of drug policy research is inclusive and diverse. Real-World Impact: Presentations at these conferences often precede major shifts in national drug strategies, providing a "sneak peek" into the next decade of global regulation. Why Membership Matters: Professional Resources for Experts Joining the ISSDP isn't just about a title; it’s about access to a curated ecosystem of specialized tools: Online Grey Literature Bibliography: A vital resource for accessing non-commercial research that often escapes mainstream journals. Excellence in Research Awards: Recognizing groundbreaking contributions that shift the needle in harm reduction and market analysis. Collaborative Networking: A platform to connect with members from the International Drug Policy Consortium (IDPC) and the Beckley Foundation. Specializations and Areas of Impact The ISSDP is uniquely positioned to handle interdisciplinary research areas: Harm Reduction Research: Analyzing the efficacy of supervised injection sites, needle exchanges, and opioid substitution therapies. International Drug Law: Studying the impact of cannabis legalization in North America and its ripple effects in Europe and South America. Drug Market Dynamics: Using advanced economic modeling to understand the supply chain of illicit substances. Contact and Institutional Information Located near the All Saints Campus of MMU, the ISSDP remains deeply rooted in the academic excellence of Greater Manchester while maintaining a global service radius. Address: c/o Manchester Metropolitan University, All Saints, Grosvenor Square, Manchester, M15 6BH, UK. Phone: +44 (0)161 247 3457 Email: enquiries@issdp.org Web: https://www.issdp.org Frequently Asked Questions 1. What is the main goal of the ISSDP? The primary goal is to advance the scientific basis for drug policy through high-quality research, providing a forum for analysts to share findings and influence global policymakers. 2. Is the ISSDP a government agency? No, the ISSDP is a vendor-neutral, non-partisan professional membership organization and a registered UK charity (Registration No. 1177654). 3. Who founded the ISSDP? The society was founded by Prof. Peter Reuter, a renowned professor of Criminology and Public Policy, who served as the Founding President. 4. Can students join the ISSDP? Yes, the ISSDP offers dedicated research scholarships and membership opportunities specifically for doctoral students and early-career researchers. 5. Where are the ISSDP conferences held? The conferences are held annually and rotate globally to different host institutions, such as Manchester Metropolitan University (2025) and Curtin University in Perth (2026). 6. Does the ISSDP support harm reduction? The ISSDP provides a platform for the scientific study of harm reduction. While the society itself remains neutral, its members produce much of the leading global research on harm reduction effectiveness. 7. How can I pay for my ISSDP membership? Accepted payment methods include Credit/Debit Cards via Stripe or Wild Apricot, Bank Transfers (EUR/GBP), and PayPal. 8. What languages are supported at ISSDP events? While English is the primary language, the society offers multilingual support (specifically Spanish and French) for its international conferences to facilitate global dialogue. 9. What is the "Grey Literature Bibliography"? It is a member-exclusive resource containing research reports, working papers, and technical findings that are not published in traditional commercial journals. 10. How do I apply for an ISSDP Excellence in Research Award? Awards are typically granted based on peer nominations and review of published research within the preceding three years. Details are announced annually via the official website.